Meta Information

ID:erythropoietin

Name:Erythropoietin

Schema Version:1.5

Alternate Names

• EPO
• Epoetin alfa

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

400

High Cost:

2000

Cost Type:

monthly

Description:

Prescription-only medication with significant cost, rarely used outside of specific medical conditions.

Summary

Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells, thereby increasing the oxygen-carrying capacity of the blood. While essential for treating anemia, its relevance to healthspan is speculative, based on preclinical data suggesting potential neuroprotective and tissue-reparative effects. However, its use in healthy individuals carries substantial risks that likely outweigh any unproven benefits.

Purpose

Hormone stimulating red blood cell production for oxygenation.

Card Summary

A hormone that boosts red blood cell production, with speculative neuroprotective effects but significant cardiovascular risks.

Drug Class

erythropoiesis-stimulating_agent

Drugs In Class

Empty Array

Impact

Score:

2.5

Justification:

Powerful physiological effects but unproven for longevity; risks likely outweigh theoretical benefits.

Evidence

Grade:

C

Score:

3

Justification:

No human healthspan trials; evidence is limited to preclinical models and clinical anemia treatment.

Safety

Score:

7.8

Justification:

High risk of thrombosis (blood clots), stroke, and hypertension without strict medical supervision.

Flags

• Requires a prescription and is a banned performance-enhancing drug in competitive sports.
• Significantly increases risk of blood clots, stroke, heart attack, and pulmonary embolism.
• Can cause or worsen hypertension (high blood pressure).
• Requires regular blood monitoring (hematocrit, hemoglobin) to avoid dangerous blood viscosity.
• May promote tumor growth in certain types of cancers.

Verdict

High-risk and unproven for healthspan; avoid outside of clinical necessity.

Created

2026-04-25T01:41:57.873501Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

subcutaneous_injection

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells, thereby increasing the oxygen-carrying capacity of the blood. While essential for treating anemia, its relevance to...

Typical Protocol

• Microdosing protocols (e.g., 20-40 IU/kg once weekly) are highly speculative and lack safety data for longevity.